134 related articles for article (PubMed ID: 38058479)
1. Evaluation of Chemotherapy Induced Peripheral Neuropathy, Sarcopenia and Fatigue in Children with Acute Lymphoblastic Leukaemia and Lymphoma in Tertiary Care Hospital, Dakshina Kannada.
Singhal N; Samuel SR; Kumar VK; Prasad H; Saraswathy MV
Indian J Palliat Care; 2023; 29(4):426-431. PubMed ID: 38058479
[TBL] [Abstract][Full Text] [Related]
2. Dexamethasone-Induced Sarcopenia and Physical Frailty in Children With Acute Lymphoblastic Leukemia: Protocol for a Prospective Cohort Study.
Verwaaijen EJ; van Hulst A; Fiocco M; Hartman A; Grootenhuis M; Pluijm S; Pieters R; van den Akker E; van den Heuvel-Eibrink MM
JMIR Res Protoc; 2022 Apr; 11(4):e33517. PubMed ID: 35403603
[TBL] [Abstract][Full Text] [Related]
3. Physical fitness throughout chemotherapy in children with acute lymphoblastic leukaemia and lymphoma.
Vriens A; Verschueren S; Vanrusselt D; Troosters T; Gielis M; Dirix V; Vanderhenst E; Sleurs C; Uyttebroeck A
Eur J Pediatr; 2023 Feb; 182(2):813-824. PubMed ID: 36482087
[TBL] [Abstract][Full Text] [Related]
4. Persistence of Chemotherapy-Induced Peripheral Neuropathy Despite Vincristine Reduction in Childhood B-Acute Lymphoblastic Leukemia.
Rodwin RL; Kairalla JA; Hibbitts E; Devidas M; Whitley MK; Mohrmann CE; Schore RJ; Raetz E; Winick NJ; Hunger SP; Loh ML; Hockenberry MJ; Angiolillo AL; Ness KK; Kadan-Lottick NS
J Natl Cancer Inst; 2022 Aug; 114(8):1167-1175. PubMed ID: 35552709
[TBL] [Abstract][Full Text] [Related]
5. Physical exercise training interventions for children and young adults during and after treatment for childhood cancer.
Braam KI; van der Torre P; Takken T; Veening MA; van Dulmen-den Broeder E; Kaspers GJ
Cochrane Database Syst Rev; 2013 Apr; (4):CD008796. PubMed ID: 23633361
[TBL] [Abstract][Full Text] [Related]
6. The changing burden of long-term health outcomes in survivors of childhood acute lymphoblastic leukaemia: a retrospective analysis of the St Jude Lifetime Cohort Study.
Mulrooney DA; Hyun G; Ness KK; Bhakta N; Pui CH; Ehrhardt MJ; Krull KR; Crom DB; Chemaitilly W; Srivastava DK; Relling MV; Jeha S; Green DM; Yasui Y; Robison LL; Hudson MM
Lancet Haematol; 2019 Jun; 6(6):e306-e316. PubMed ID: 31078468
[TBL] [Abstract][Full Text] [Related]
7. Physical exercise training interventions for children and young adults during and after treatment for childhood cancer.
Braam KI; van der Torre P; Takken T; Veening MA; van Dulmen-den Broeder E; Kaspers GJ
Cochrane Database Syst Rev; 2016 Mar; 3(3):CD008796. PubMed ID: 27030386
[TBL] [Abstract][Full Text] [Related]
8. Comparison of two chemotherapy-induced peripheral neuropathy measurement approaches in children.
Gilchrist LS; Marais L; Tanner L
Support Care Cancer; 2014 Feb; 22(2):359-66. PubMed ID: 24072474
[TBL] [Abstract][Full Text] [Related]
9. The utility of a portable muscle ultrasound in the assessment of muscle alterations in children with acute lymphoblastic leukaemia.
Verwaaijen EJ; van Hulst AM; Molinger J; Hartman A; Pieters R; Grootenhuis MA; van den Akker ELT; van den Heuvel-Eibrink MM
J Cachexia Sarcopenia Muscle; 2023 Oct; 14(5):2216-2225. PubMed ID: 37562959
[TBL] [Abstract][Full Text] [Related]
10. Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis.
Cheung YT; Sabin ND; Reddick WE; Bhojwani D; Liu W; Brinkman TM; Glass JO; Hwang SN; Srivastava D; Pui CH; Robison LL; Hudson MM; Krull KR
Lancet Haematol; 2016 Oct; 3(10):e456-e466. PubMed ID: 27658980
[TBL] [Abstract][Full Text] [Related]
11. Results of treatment of lymphoblastic lymphoma at the children cancer hospital Egypt - A single center experience.
Rahman Sayed HA; Sedky M; Hamoda A; Kinaaie NE; Wakeel ME; Hesham D
J Egypt Natl Canc Inst; 2016 Sep; 28(3):175-81. PubMed ID: 27339800
[TBL] [Abstract][Full Text] [Related]
12. Assessment of proxy-reported responses as predictors of motor and sensory peripheral neuropathy in children with B-lymphoblastic leukemia.
Rodwin RL; DelRocco NJ; Hibbitts E; Devidas M; Whitley MK; Mohrmann CE; Schore RJ; Raetz E; Winick NJ; Hunger SP; Loh ML; Hockenberry MJ; Ma X; Angiolillo AL; Ness KK; Kairalla JA; Kadan-Lottick NS
Pediatr Blood Cancer; 2023 Nov; 70(11):e30634. PubMed ID: 37592363
[TBL] [Abstract][Full Text] [Related]
13. Incidence of chemotherapy-induced peripheral neuropathy within 12 weeks of starting neurotoxic chemotherapy for multiple myeloma or lymphoma: a prospective, single-center, observational study.
Ajewole VB; Cox JE; Swan JT; Chikermane SG; Lamoth B; Iso T; Okolo LO; Ford CL; Schneider AM; Hobaugh EC; Baker KR
Support Care Cancer; 2020 Apr; 28(4):1901-1912. PubMed ID: 31359183
[TBL] [Abstract][Full Text] [Related]
14. Rates of laboratory adverse events by course in paediatric leukaemia ascertained with automated electronic health record extraction: a retrospective cohort study from the Children's Oncology Group.
Miller TP; Getz KD; Li Y; Demissei BG; Adamson PC; Alonzo TA; Burrows E; Cao L; Castellino SM; Daves MH; Fisher BT; Gerbing R; Grundmeier RW; Krause EM; Lee J; Lupo PJ; Rabin KR; Ramos M; Scheurer ME; Wilkes JJ; Winestone LE; Hawkins DS; Gramatges MM; Aplenc R
Lancet Haematol; 2022 Sep; 9(9):e678-e688. PubMed ID: 35870472
[TBL] [Abstract][Full Text] [Related]
15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy-induced Peripheral Neuropathy Among Paediatric Oncology Patients.
Purser MJ; Johnston DL; McMillan HJ
Can J Neurol Sci; 2014 Jul; 41(4):442-7. PubMed ID: 24878467
[TBL] [Abstract][Full Text] [Related]
17. A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN).
Schloss JM; Colosimo M; Airey C; Masci P; Linnane AW; Vitetta L
Support Care Cancer; 2017 Jan; 25(1):195-204. PubMed ID: 27612466
[TBL] [Abstract][Full Text] [Related]
18. Nelarabine, intensive L-asparaginase, and protracted intrathecal therapy for newly diagnosed T-cell acute lymphoblastic leukaemia in children and young adults (ALL-T11): a nationwide, multicenter, phase 2 trial including randomisation in the very high-risk group.
Sato A; Hatta Y; Imai C; Oshima K; Okamoto Y; Deguchi T; Hashii Y; Fukushima T; Hori T; Kiyokawa N; Kato M; Saito S; Anami K; Sakamoto T; Kosaka Y; Suenobu S; Imamura T; Kada A; Saito AM; Manabe A; Kiyoi H; Matsumura I; Koh K; Watanabe A; Miyazaki Y; Horibe K
Lancet Haematol; 2023 Jun; 10(6):e419-e432. PubMed ID: 37167992
[TBL] [Abstract][Full Text] [Related]
19. Pulse therapy with vincristine and dexamethasone for childhood acute lymphoblastic leukaemia (CCCG-ALL-2015): an open-label, multicentre, randomised, phase 3, non-inferiority trial.
Yang W; Cai J; Shen S; Gao J; Yu J; Hu S; Jiang H; Fang Y; Liang C; Ju X; Wu X; Zhai X; Tian X; Wang N; Liu A; Jiang H; Jin R; Sun L; Yang M; Leung AWK; Pan K; Zhang Y; Chen J; Zhu Y; Zhang H; Li C; Yang JJ; Cheng C; Li CK; Tang J; Zhu X; Pui CH
Lancet Oncol; 2021 Sep; 22(9):1322-1332. PubMed ID: 34329606
[TBL] [Abstract][Full Text] [Related]
20. Assessment of sensorimotor and strength related function of breast cancer patients during systemic drug therapy: a prospective observational study.
Tuğral A; Arıbaş Z; Akyol M; Bakar Y
BMC Cancer; 2023 Oct; 23(1):981. PubMed ID: 37838686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
